Drug
Bupivacaine Liposome T Preparation
Bupivacaine Liposome T Preparation: highest development phase Phase 1, developed by Jiangsu Hengrui Medicine. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Jiangsu Hengrui Medicine
Trials
| Drug | Phase | Indication |
|---|---|---|
| Bupivacaine Liposome Injection T preparation NCT07279155 | Phase 1 | Postoperative Local Analgesia |
Latest
No recent events.
Follow Bupivacaine Liposome T Preparation on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.